竹内勤 日本の医師、医学者
竹内, 勤, 1955-
Takeuchi, Tsutomu, 1955-
다케우치 쓰토무 1955-
竹内, 勤
VIAF ID: 118919460 (Personal)
Permalink: http://viaf.org/viaf/118919460
Preferred Forms
- 100 1 _ ‡a Takeuchi, Tsutomu ‡d 1955-
- 100 1 _ ‡a Takeuchi, Tsutomu, ‡d 1955-
- 100 1 _ ‡a 竹内, 勤
- 100 1 _ ‡a 竹内, 勤, ‡d 1955-
- 100 0 _ ‡a 竹内勤 ‡c 日本の医師、医学者
- 100 1 _ ‡a 다케우치 쓰토무 ‡d 1955-
4xx's: Alternate Name Forms (18)
Works
Title | Sources |
---|---|
Baio sekyuriti no kōjō ni shisuru kōshū eisei sochi ni kansuru chōsa kenkyū hōkokusho | |
Fāma nabigētā riumachi seibutsugakuteki seizaihen | |
Gurōbaru jidai no kansenshō, 2004: | |
Honki de naoshitai hito no kogenbyo riumachi : Saishinban. | |
Kansetsu riumachi chiryo jissen baiburu. | |
lnterleukin-4 and IgE in Seasonal Allergic Conjunctivitis | |
Notable difference between the development of vertebral fracture and osteonecrosis of the femoral head in patients treated with high-dose glucocorticoids for systemic rheumatic diseases. | |
Osteolytic change of distal interphalangeal joints and sacroiliac joints in subluxing arthropathy associated with anti-Jo-1 antibody | |
Polymyositis with elevated serum IgG4 levels and abundant IgG4+ plasma cell infiltration: A case report and literature review | |
Post-marketing surveillance study of the long-term use of mizoribine for the treatment of lupus nephritis: 2-Year results | |
Primary natural killer cell lymphoma of the lacrimal sac. | |
Priorities in health | |
Proteomic identification of heterogeneous nuclear ribonucleoprotein K as a novel cold-associated autoantigen in patients with secondary Raynaud's phenomenon. | |
RANKL: A therapeutic target for bone destruction in rheumatoid arthritis. | |
[Recent progress in the medical treatment of rheumatoid arthritis] | |
Reduction of plasma IL-6 but not TNF-α by methotrexate in patients with early rheumatoid arthritis: a potential biomarker for radiographic progression. | |
Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjögren's syndrome | |
Remission induction by Raising the dose of Remicade in RA (RRRR) study: Rationale and study protocol for a randomized controlled trial comparing for sustained clinical remission after discontinuation of infliximab in patients with rheumatoid arthrit | |
Resolution of elevated circulating regulatory T cells by corticosteroids in patients with IgG4-related dacryoadenitis and sialoadenitis. | |
[Respiratory failure in polymyositis and dermatomyositis: differential diagnosis between pulmonary infection and interstitial pneumonitis] | |
Respiratory syncytial virus-induced interleukin-4 production by human conjunctival epithelial cells contributes to allergy: preliminary study | |
Response to: 'Denosumab, cortical bone and bone erosion in rheumatoid arthritis' by Rossini et al. | |
Response to e-letter: 'Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment' by Lee | |
Restoration of Decreased T Helper 1 and CD8+ T Cell Subsets Is Associated With Regression of Lymphoproliferative Disorders Developed During Methotrexate Treatment. | |
Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of joint destruction (RECONFIRM-2J). | |
Revolutionary change in rheumatoid arthritis management with biological therapy | |
Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: A hospital based-cohort study. | |
Risk factors for the recurrence of interstitial lung disease in patients with polymyositis and dermatomyositis: a retrospective cohort study. | |
Riumachi : Atarashii chiryōhō ga kuwashiku wakaru byōki to maemuki ni tsukiau tameno jōhō ga mansai | |
Riumachi kōgenbyō : Byōkibetsu chiryō no saisentan to itami o yawarageru pointo : Saishin igaku ga tokoton wakaru | |
Riumachi kogenbyo shinryo goruden handobukku. | |
Riumachi : Saishin no yakubutsu ryoho to rihabiri. | |
Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan | |
Safety and effectiveness of tacrolimus add-on therapy for rheumatoid arthritis patients without an adequate response to biological disease-modifying anti-rheumatic drugs (DMARDs): Post-marketing surveillance in Japan. | |
Safety and efficacy of long-term esomeprazole 20 mg in Japanese patients with a history of peptic ulcer receiving daily non-steroidal anti-inflammatory drugs. | |
Safety, pharmacokinetics, and efficacy of E6011, an antifractalkine monoclonal antibody, in a first-in-patient phase 1/2 study on rheumatoid arthritis. | |
Secukinumab after anti-tumour necrosis factor-α therapy: a phase III study in active rheumatoid arthritis. | |
Sensitivity and specificity of 2010 rheumatoid arthritis classification criteria. | |
Severe degenerative change of multiple organs mediated by chronic active Epstein-Barr virus infection with infected T-cell expansion | |
Shin rinshō kensa gishi kōza. | |
Significant association between clinical characteristics and changes in peripheral immuno-phenotype in large vessel vasculitis | |
Single center prospective study of tacrolimus efficacy and safety in the treatment of various manifestations in systemic lupus erythematosus | |
Sirukumab in rheumatoid arthritis refractory to sulfasalazine or methotrexate: a randomized phase 3 safety and efficacy study in Japanese patients. | |
Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis. | |
Spontaneous production of antibodies to deoxyribonucleic acids in patients with systemic lupus erythematosus | |
Successful resumption of tocilizumab for rheumatoid arthritis after resection of a pulmonary Mycobacterium avium complex lesion: a case report | |
Successful treatment of embryo implantation failure in patients with the Sjögren syndrome with low-dose prednisolone | |
Suppression of in Vitro Production of Anti-U1-Ribonucleoprotein Antibody by Monoclonal Anti-Idiotypic Antibody to Anti-U1-Ribonucleoprotein Antibody | |
Suppressor t cell function in patients with rheumatoid arthritis complicated by vasculitis | |
Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis | |
A unique case of polymyositis with anti-signal recognition particle antibody complicated by subacute interstitial lung disease and subluxing arthropathy, resembling anti-synthetase syndrome | |
Zenshinsei eritematodesu. | |
バイオセキュリティの向上に資する公衆衛生措置に関する調查研究報告書 | |
バイオセキュリティ分野の国際連携協力に関する研究調查報告書 | |
リウマチ・アレルギー疾患の治療反応性予測因子の確立及びテーラーメイド治療法の確立に関する研究 | |
リウマチ : 新しい治療法が詳しくわかる病気と前向きにつき合うための情報が満載 | |
リウマチ : 最新の薬物療法とリハビリ | |
リウマチ : 生物学的製剤編 | |
リウマチ・膠原病 : 病気別治療の最先端と痛みをやわらげるポイント : 最新医学がとことんわかる | |
リウマチ・膠原病のすべて | |
リウマチ・膠原病診療ゴールデンハンドブック = Golden Handbook of Rheumatology | |
全身性エリテマトーデス | |
臨床検查技術学. | |
免疫・炎症疾患のすべて | |
関節リウマチ : "治癒をめざす"最新治療コンセンサス | |
関節リウマチ治療実践バイブル | |
国際保健の優先課題 | |
本気で治したい人の膠原病・リウマチ : 最新版 | |
新臨床検查技師講座. | |
膠原病・リウマチは治る |